| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/06/2001 | WO2001092300A2 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/06/2001 | WO2001092284A1 Nucleotide analogues comprising a reporter moiety and a polymerase enzyme blocking moiety |
| 12/06/2001 | WO2001092279A2 Haplotypes of the aldh5 gene |
| 12/06/2001 | WO2001092278A2 Haplotypes of the rlbp1 gene |
| 12/06/2001 | WO2001091805A2 Compounds for targeting endothelial cells |
| 12/06/2001 | WO2001091629A2 Methods for detecting dna damage and screening for cancer therapeutics |
| 12/06/2001 | WO2001091625A2 Methods and compositions for the diagnosis of schizophrenia |
| 12/06/2001 | WO2001073119A9 Methods for genotyping by hybridization analysis |
| 12/06/2001 | WO2001068805A8 Human olfactory receptors and genes encoding same |
| 12/06/2001 | WO2001064957A8 Polymorphisms associated with insulin-signaling and glucose-transport pathways |
| 12/06/2001 | WO2001064922A3 Heterologous expression of neisserial proteins |
| 12/06/2001 | WO2001057271A8 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and bt 474 cells |
| 12/06/2001 | WO2001055387A8 Nucleic acids, proteins, and antibodies |
| 12/06/2001 | WO2001055313A8 Nucleic acids, proteins, and antibodies |
| 12/06/2001 | WO2001053351A3 Apoptin bindendes protein |
| 12/06/2001 | WO2001052614A3 Selecting and producing t cell peptide epitopes |
| 12/06/2001 | WO2001049880A3 Primers, in particular, for primer-dependent nucleic acid synthesis processes and nucleic acid amplification methods |
| 12/06/2001 | WO2001049717A3 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity |
| 12/06/2001 | WO2001048240A3 Implication of a known gene named cp2/lsf-lbp-1 in alzheimer's desease |
| 12/06/2001 | WO2001046224A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/06/2001 | WO2001044819A3 Hematological assay and reagent |
| 12/06/2001 | WO2001040510A3 Dynamic sequencing by hybridization |
| 12/06/2001 | WO2001040509A3 Dynamic determination of analytes |
| 12/06/2001 | WO2001038877A9 Multiblot kinase analysis |
| 12/06/2001 | WO2001036670A3 Diagnosis kit, method and microarray for determining human detoxification capacity |
| 12/06/2001 | WO2001036669A3 Method for the controlled implementation of complex pcr amplifications |
| 12/06/2001 | WO2001034201A3 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 12/06/2001 | WO2001032909A3 Method of detecting the presence or absence of specific genes |
| 12/06/2001 | WO2001032864A3 Gpcr-kd5 polypeptides and dna sequences thereof |
| 12/06/2001 | WO2001029248B1 Method for amplifying and detecting nucleic acid |
| 12/06/2001 | WO2001027313A3 Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 2 gene |
| 12/06/2001 | WO2001023607A3 Multiplex pcr for detecting ehec infections |
| 12/06/2001 | WO2001021840A3 Indexing populations |
| 12/06/2001 | WO2001020036A3 Methods of using a major histocompatibility complex class iii haplotype to diagnose crohn's disease |
| 12/06/2001 | WO2001020035A3 Methods and compositions for linear isothermal amplification of polynucleotide sequences |
| 12/06/2001 | WO2001018246A8 Microfluidic and nanofluidic electronic devices for detecting changes in capacitance of fluids and methods of using |
| 12/06/2001 | WO2001018042A3 Apoptosis proteins |
| 12/06/2001 | WO2001012775A8 25 human secreted proteins |
| 12/06/2001 | WO2001012662A3 Membrane associated proteins |
| 12/06/2001 | WO2001011359A3 Color space analysis in biochemical and immunological assays |
| 12/06/2001 | WO2001011075A3 Pcr-based detection and quantification of tapesia yallundae and tapesia acuformis |
| 12/06/2001 | WO2000077206A3 The myostatin gene promoter and inhibition of activation thereof |
| 12/06/2001 | WO2000063427A3 Compound screening method |
| 12/06/2001 | WO2000061811A3 Method of predicting susceptibility to hiv infection or progression of hiv disease |
| 12/06/2001 | WO2000061750A3 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
| 12/06/2001 | WO2000011166A9 14274 receptor, a g-protein coupled receptor related to the edg receptor family |
| 12/06/2001 | WO2000006599A8 Inhibitors of hiv membrane fusion |
| 12/06/2001 | US20010049586 Iterative analysis of non-responding population in the design of pharmacogenetic studies |
| 12/06/2001 | US20010049438 Purification of primer extension products |
| 12/06/2001 | US20010049437 Electrophoretic separation of nucleic acids from proteins at low ph |
| 12/06/2001 | US20010049435 Myostatin gene promoter and inhibition of activation thereof |
| 12/06/2001 | US20010049432 Human semaphorin ZSMF-16 |
| 12/06/2001 | US20010049360 Betaglycan as an inhibin receptor and uses thereof |
| 12/06/2001 | US20010049348 Interaction of NMDA receptor with protein tyrosine phosphatase |
| 12/06/2001 | US20010049139 Transplantation of hematopoietic stem cells to repopulate functional hepatocytes; in vitro cell culture of regenerating hepatocytes generated from a human cell population; screening for genetic sequences using hybridization of an RNA probe |
| 12/06/2001 | US20010049137 DNA fragments derived from the genomic DNA of HPV-33, including recombinant vectors, which cells are replicated in host cells and expressed as immunogenic proteins; diagnosis of tumors; antibodies to detect viral infections |
| 12/06/2001 | US20010049134 Using an electrically conducting polymer which emits heat when an electric current is supplied; different currents achieve different temperatures very rapidly; bioreactions, e.g. amplification of DNA using the polymerase chain reaction |
| 12/06/2001 | US20010049125 Amplifying a target nucleotide, involving generating concatemers formed by polymerase chain reaction (PCR) amplification of overlapping fragments; kit comprising a bivalent primer and instructions |
| 12/06/2001 | US20010049123 Nucleotide sequences encoding the dapC gene and process for the production of L-lysine |
| 12/06/2001 | US20010049122 For reducing inflammation, for treating an autoimmune disease, for enhancing transplantation of tissue grafts, increasing antitumor immunity, and inhibiting viral and parasitic infections |
| 12/06/2001 | US20010049121 Polypeptides and polynucleotides; drug screening, use in therapy, diagnostic assays |
| 12/06/2001 | US20010049120 Expression vector for consistent cellular expression of the tet on repressor in multiple cell types |
| 12/06/2001 | US20010049117 Uridine diphosphate N-acetylmuramyl peptide (UDP-MURNAC) analog with capture moiety; substrate for enzyme in bacterial cell wall biosynthesis; screening for new antibiotics |
| 12/06/2001 | US20010049116 Incubating the sample with a solubilization buffer to solubilize a molecular marker of the parasite and detecting at a given concentration; kits for immunoassay; water testing, fecal testing |
| 12/06/2001 | US20010049111 Methods, procedures, and formats for using microelectronic array devices to perform multiplex immunoassay analyses |
| 12/06/2001 | US20010049110 Sample treating kit and sample treating method using the same for analysis with a biosensor |
| 12/06/2001 | US20010049109 Comprising a donor dye having a specified absorption maxima, and an acceptor dye capable of absorbing excitation energy emitted by the donor dye and emitting light in response of given emission maxima |
| 12/06/2001 | US20010049108 Methods for reducing non-specific binding to an oligonucleotide array |
| 12/06/2001 | US20010049106 ADAM (A Disintegrin And Metalloprotease) family of metalloproteases, and in addition contain thrombospondin domain (TS); treating diabetes, arthritis, cancer, solid tumors, autoimmune diseases |
| 12/06/2001 | US20010049105 Electrophoretic tag (e-tag) probes; detection involves the release of identifying tags as a consequence of target recognition |
| 12/06/2001 | US20010049103 Identifying a gene encoding an RNA modification enzyme (RME), using a library of bacterial genes; new antibiotic discovery |
| 12/06/2001 | US20010049102 Partial chain termination sequencing reactions of a target nucleic acid of interest conducted with the four deoxynucleotides but only one to three non-extendible nucleotides, selected to be complementary to variant site |
| 12/06/2001 | US20010049100 Exposing cells to a chromosome damaging agent to fragment chromosomes, marking chromosome fragments, and analyzing the marked chromosome fragments to determine if cells were affected by the disease, such as Alzheimer's |
| 12/06/2001 | US20010049097 Method of improved transcript extension of noncanonical transcripts using mutant rna polymerases |
| 12/06/2001 | US20010049096 Sample identification with analyte determination |
| 12/06/2001 | US20010049095 Genetic engineering; using computers |
| 12/06/2001 | US20010049094 Accurate isolation, detection |
| 12/06/2001 | US20010049092 Method and device for drug-drug interaction testing sample preparation |
| 12/06/2001 | US20010049091 Use of fluorescent reagents in identification of cancerous cells and activated lymphocytes |
| 12/06/2001 | US20010049090 Immobilized on solid support; encoded with label |
| 12/06/2001 | US20010048928 Herpesvirus particles comprising fusion protein and their preparation and use |
| 12/06/2001 | US20010048917 Skin equivalent and methods of forming and using same |
| 12/06/2001 | US20010048899 Delivering fluid to sample holder utilizing a pump connected to fluid source, conduit path extending from the pump to dispenser remains open and unconstricted between deposition of fluid aliquots |
| 12/06/2001 | US20010048895 Laboratory in a disk |
| 12/06/2001 | US20010048756 Method of newborn indentification and tracking |
| 12/06/2001 | US20010047966 Filtering sample of digested natural sources such as cells or cell fragments using filter the pore size of which decreases in direction of flow of sample through filter |
| 12/06/2001 | DE10027218A1 Detecting heterogeneous nucleic acid sequences in organisms and cells, useful for detecting and identifying genetically modified organisms or their products |
| 12/06/2001 | DE10027040A1 Verfahren zur Herstellung von DNA-Arrays A process for producing DNA arrays |
| 12/06/2001 | DE10025174A1 Verfahren zur Herstellung einer mit Biomolekülen beschichteten Elektrode A process for producing a surface coated with biomolecules electrode |
| 12/06/2001 | DE10017675A1 Verfahren zur Identifizierung und Isolierung von Genomfragmenten mit Kopplungsungleichgewicht A process for the identification and isolation of genomic fragments with linkage disequilibrium |
| 12/06/2001 | CA2421031A1 No wash bead assay, kit and procedure |
| 12/06/2001 | CA2415224A1 Methods for using mass spectrometry to identify and classify filamentous fungi, yeasts, molds and pollen |
| 12/06/2001 | CA2414017A1 Inhibiting retrotransposon and retroviral integration by targeting the atm pathway |
| 12/06/2001 | CA2411655A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | CA2411404A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | CA2411315A1 Method for detecting a detectable product |
| 12/06/2001 | CA2411304A1 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/06/2001 | CA2410950A1 Methods for detecting target nucleic acids using coupled ligation and amplification |
| 12/06/2001 | CA2410949A1 Novel target genes for diseases of the heart |
| 12/06/2001 | CA2410947A1 Methods for mediating gene suppresion by using factors that enhance rnai |